Mersana Therapeutics, Inc.
MRSNCIK 0001442836 · Every Form 4 filed by insiders at this issuer.
Filings
13
Latest Feb 16, 2024
Unique insiders
12
Showing
13 of 13
Page 1
Top insiders
Most active reporters at Mersana Therapeutics, Inc.
| Name | Roles | Filings |
|---|---|---|
| Mandelia Ashish | Officer | 2 |
| Alleva Lawrence M | Director | 1 |
| Bala Mohan | Officer | 1 |
| Carvajal Alejandra | Officer | 1 |
| DeSchuytner Brian | Officer | 1 |
| Dere Willard H | Director | 1 |
| Hege Kristen | Director | 1 |
| Huber Martin H. Jr. | OfficerDirector | 1 |
| Lowinger Timothy B | Officer | 1 |
| MISRA TUSHAR | Officer | 1 |
All filings
13 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Feb 16, 2024 | Mandelia Ashish VP, Chief Accounting Officer | Holdings only | — | — | — | |
| Jan 17, 2024 | Bala Mohan SVP, Chief Development Officer | S | 3,431 | $2.71 | $9,298 | |
| Jan 17, 2024 | DeSchuytner Brian SVP, COO & CFO | S | 9,327 | $2.71 | $25,276 | |
| Jan 17, 2024 | Carvajal Alejandra SVP, Chief Legal Officer | S | 4,381 | $2.71 | $11,873 | |
| Jan 17, 2024 | Huber Martin H. Jr. President, CEO · Director | Holdings only | — | — | — | |
| Jan 17, 2024 | Lowinger Timothy B SVP, Chief Sci.&Tech. Officer | S | 10,409 | $2.71 | $28,208 | |
| Jan 17, 2024 | Mandelia Ashish VP, Chief Accounting Officer | S | 5,025 | $2.71 | $13,618 | |
| Jan 17, 2024 | MISRA TUSHAR SVP, Chief Manuf. Officer | S | 3,357 | $2.71 | $9,097 | |
| Jan 17, 2024 | Protopapas Anna Director | S | 29,399 | $2.71 | $79,671 | |
| Jan 4, 2024 | MOTT DAVID M Director | A | 8,810 | $0.00 | $0 | |
| Jan 4, 2024 | Dere Willard H Director | A | 6,112 | $0.00 | $0 | |
| Jan 4, 2024 | Hege Kristen Director | Holdings only | — | — | — | |
| Jan 4, 2024 | Alleva Lawrence M Director | Holdings only | — | — | — |
Showing 1–13 of 13
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.